Evidence map›Paper›PMID 28845090›Full record

ArticleMediators of inflammation2017

The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics.

Yahui Liu, Tian Liu, Jinxiang Wu, Tao Li, Xingai Jiao, Haiqing Zhang, Jiping Zhao, Junfei Wang, Lin Liu, Liuzhao Cao and 6 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. FSTL1 aggravates OVA-induced inflammatory responses by activating the NLRP3/IL-1β signaling pathway in mice and macrophages.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Follistatin-like 1 in development and human diseases.Cellular and molecular life sciences : CMLS · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Yahui LiuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Tian LiuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Jinxiang WuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Tao LiDepartment of Pulmonary Medicine-Bronchoscopy Room, Qilu Hospital of Shandong University, Jinan 250012, China.
Xingai JiaoDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Haiqing ZhangDepartment of Pulmonary Medicine-Bronchoscopy Room, Qilu Hospital of Shandong University, Jinan 250012, China.
Jiping ZhaoDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Junfei WangDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Lin LiuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Liuzhao CaoDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Shuo LiDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Jiawei XuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Jianfeng XuDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Xiaohui MaDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Lei YangDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Liang DongDepartment of Pulmonary Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.ORCID 0000-0001-7707-9982
Qilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma is characterized by airway remodeling. Follistatin-like protein 1 (FSTL1) is an extracellular glycoprotein. Recent studies suggest that FSTL1 may participate in the pathogenesis of asthma.

objectivesTo analyze the association between FSTL1 and some parameters and inspect the role of FSTL1 in asthma.

methodsWe examined FSTL1 levels in 32 asthmatics and 25 controls. All subjects enrolled had routine blood tests, spirometry, and impulse oscillometry performed. Additionally, 15 of the 32 asthmatics underwent fibre optic bronchoscopy. Spearman rank analysis was performed to detect the correlation between FSTL1 and other parameters.

resultsPlasma FSTL1 levels were higher in asthmatics (130.762 ± 46.029 ng/mL) than in controls (95.408 ± 33.938 ng/mL) (

conclusionsFSTL1 levels in asthmatics were linked with increased smooth muscle mass and thickened RBM. FSTL1 may contribute to airway remodeling in asthmatics.

Indexed as

AdultAirway RemodelingAsthmaBronchiBronchoalveolar Lavage FluidBronchoscopyFemaleFollistatin-Related ProteinsHumansMaleMiddle AgedMuscle, SmoothYoung AdultFollistatin-Related ProteinsFSTL1 protein, human

Identifiers

PMID28845090
PMCPMC5560092
OpenAlexW2742613651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.